By Sneha S K and Kamal Choudhury Oct 2 (Reuters) - An advisory panel to the US Food and Drug Administration handed Grail's ...

One blood draw flagged cancers doctors would usually miss until much later, and most were early enough to still be treatable.

Or had her cancer returned? “Because I have the BRCA2 gene, I have a higher chance of the cancer coming back,” she says. “The ...

A controversial blood test aimed at detecting multiple cancers was backed by a U.S. Food and Drug Administration panel.

The panelists expressed reservations about the evidence supporting Grail’s Galleri test, which is designed to detect cancers early.

Recent research suggests that monitoring blood test trends over time, rather than focusing on a single test, may help ...

A new blood test could diagnose pancreatic cancer much earlier, improving survival rates for people with the disease. A large part of the reason for this poor prognosis is that pancreatic cancer is ...

Want to B-positive about your health? Johns Hopkins researchers have developed a cutting-edge blood test that can detect signs of cancer three years before any symptoms surface. The breakthrough could ...

The early study involved people with chronic obstructive pulmonary disease, or COPD, who were at increased risk of lung cancer. Researchers detected circulating tumor cells in five participants one to ...

A nanoparticle-enabled blood proteomics test can measure tumour hypoxia in bladder cancer patients, track it during ...

Only Abbott offers a complete screening solution combining end-to-end support with both stool- and blood-based colorectal ...

A circulating tumor HPV DNA blood test detected every recurrence of HPV-associated throat cancer after surgery with no false ...